PAD Profile : Olanzapine - Parkinson's Disease (psychosis)

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Olanzapine - Parkinson's Disease (psychosis)

Keywords :

psychotic symptoms, PD, hallucinations, delusions, psychosis in Parkinson's disease

Brand Names Include :

Zyprexa

Traffic Light Status

Status :

Non Formulary

Formulations :

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

NFD1

Comments :

No comments returned.

Documents :

No guidelines returned.

Type

Document

Review Date

Guidelines (National)

Date

Committee Name

Narrative

06 June 2018

Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

NICE does not recommend the use of olanzapine to treat hallucinations and delusions in Parkinson's disease

04. Central Nervous System

04.02.01. Antipsychotic drugs